Literature DB >> 4034367

Effect of adenosine and its stabile analogue 2-chloroadenosine on cerebrocortical microcirculation and NAD/NADH redox state.

E Dóra.   

Abstract

In the present study, the effects of topically applied adenosine (ADO) and its stabile analogue 2-chloroadenosine (CADO) on cerebrocortical microcirculation and NAD/NADH redox state (oxidized/reduced nicotinamide adenine dinucleotide) were investigated. Vascular volume (CVV), mean transit time of blood flow (tm), blood flow (CBF), and NADH fluorescence of the cat brain cortex were measured through a cranial window with a microscope fluororeflectometer. The reference values of CVV, tm, and CBF, measured in the artificial cerebrospinal fluid (mock CSF) which superfused brain cortex, were regarded as 100%. Adenosine and 2-chloroadenosine, in the concentration range of 10(-6) - 10(-3) M, resulted in concentration-dependent increases in CBF and NAD reduction. 10(-5) M adenosine and 2-chloroadenosine increased CBF by 49.6 +/- 5.6% and 80.4 +/- 10.3%, respectively. At a pharmacologically high concentration (10(-3) M), ADO increased CBF by 164.6 +/- 13.5%, CADO by 333 +/- 44%. At the same time, 10(-3) M ADO and CADO shifted the cortical NAD/NADH redox state by 7.9 +/- 0.4% and 12.4 +/- 0.7%, respectively toward a more reduced state. Our results, concerning the vasodilator potency of adenosine and 2-chloroadenosine, accord with available data in the literature. However, the pronounced NAD reduction obtained with these adenosine nucleosides suggests that, besides an action on vascular adenosine receptors, some other changes, such as increased substrate mobilization and possibly cAMP production, may contribute to the vasodilator effect of adenosine and 2-chloroadenosine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4034367     DOI: 10.1007/bf00581241

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  35 in total

1.  Evidence against H+ and K+ as main factors for the control of cerebral blood flow: a microelectrode study.

Authors:  J Astrup; D Heuser; N A Lassen; B Nilsson; K Norberg; B K Siesjö
Journal:  Ciba Found Symp       Date:  1978-03

2.  The dilatatory action of adenosine on pial arteries of cats and its inhibition by theophylline.

Authors:  M Wahl; W Kuschinsky
Journal:  Pflugers Arch       Date:  1976-03-11       Impact factor: 3.657

3.  Adenosine and cyclic AMP in cerebral cortex of rats in hypoxia, status epilepticus and hypercapnia.

Authors:  S Rehncrona; B K Siesjö; E Westerberg
Journal:  Acta Physiol Scand       Date:  1978-12

4.  Coupling of cerebral metabolism and blood flow in epileptic seizures, hypoxia and hypoglycaemia.

Authors:  B Nilsson; S Rehncrona; B K Siesjö
Journal:  Ciba Found Symp       Date:  1978-03

5.  Induced hemodilution detected by reflectometry for measuring microregional blood flow and blood volume in cat brain cortex.

Authors:  A Eke; G Hutiray; A G Kovách
Journal:  Am J Physiol       Date:  1979-05

6.  Correlation between PaCO2 and regional cerebral blood volume by x-ray fluorescence.

Authors:  M E Phelps; R L Grubb; M M Ter-Pogossian
Journal:  J Appl Physiol       Date:  1973-08       Impact factor: 3.531

7.  Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure.

Authors:  J Schrader; M Wahl; W Kuschinsky; G W Kreutzberg
Journal:  Pflugers Arch       Date:  1980-09       Impact factor: 3.657

8.  Influence of H+ on K+ on adenosine-induced dilatation at pial arteries of cats.

Authors:  M Wahl; W Kuschinsky
Journal:  Blood Vessels       Date:  1977

9.  A simple cranial window technique for optical monitoring of cerebrocortical microcirculation and NAD/NADH redox state. Effect of mitochondrial electron transport inhibitors and anoxic anoxia.

Authors:  E Dóra
Journal:  J Neurochem       Date:  1984-01       Impact factor: 5.372

10.  Alkaline and acid transients in cerebellar microenvironment.

Authors:  R P Kraig; C R Ferreira-Filho; C Nicholson
Journal:  J Neurophysiol       Date:  1983-03       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.